Kevin Kuo
University Health Network, Toronto General Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Kevin Kuo as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 20:30 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT04432623 · The BENeFiTS Trial in Beta Thalassemia IntermediaPhoenicia BioScience · enrolling by invitation · Beta Thalassemia Intermedia, Sickle Cell Disease · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 20:30 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Development of a Clinical Hemoglobin ModulatorR33HL147845 · NHLBI · PHOENICIA BIOSCIENCES, INC. · fiscal years 2020 to 2022 · $1,630,002 awarded in 2022Grant number is on one of their registry trials
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 20:30 UTC. The ranking covers the 200 most relevant of 41 PubMed records, and a shared surname and initials can bring in a namesake. All 41 on PubMed
- A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia.N Engl J Med · 2020253 citationsRCR 12.3
- Secretory dynamics of ghrelin in adolescent girls with anorexia nervosa and healthy adolescents.Am J Physiol Endocrinol Metab · 2005136 citationsRCR 4.1
- Safety and Efficacy of Mitapivat in Pyruvate Kinase Deficiency.N Engl J Med · 2019127 citationsRCR 5.2
- A pilot randomized controlled trial to improve geriatric frailty.BMC Geriatr · 2012113 citationsRCR 4.6
- Intravenous iron exacerbates oxidative DNA damage in peripheral blood lymphocytes in chronic hemodialysis patients.J Am Soc Nephrol · 200882 citationsRCR 2.4
- Integrated care for geriatric frailty and sarcopenia: a randomized control trial.J Cachexia Sarcopenia Muscle · 201780 citationsRCR 3.9
- 77 citationsRCR 6.2
- 67 citationsRCR 2.9
- Mitapivat in adult patients with pyruvate kinase deficiency receiving regular transfusions (ACTIVATE-T): a multicentre, open-label, single-arm, phase 3 trial.Lancet Haematol · 202247 citationsRCR 3.7
- Long-term dynamics of bone mineral density during intermittent androgen deprivation for men with nonmetastatic, hormone-sensitive prostate cancer.J Clin Oncol · 201231 citationsRCR 0.9